We’re pleased to share that Linnea’s updated GMP certificate and MIA have now been formally published by Swissmedic and are available on the EU database.
This marks the official recognition of our expanded GMP certification, which now includes THC extracts and combinations, along with Cannabigerol (CBG) and CBD:CBG combinations – a milestone we first announced earlier this year.
This publication further reinforces Linnea’s commitment to quality, transparency, and regulatory excellence in the development of standardized cannabis-based formulations for therapeutic use.
A huge thank you to our dedicated team, both the core team in the picture and all the colleagues working behind the scenes whose expertise and commitment made this achievement possible. Together, we continue to drive innovation and reliability in the field of pharmaceutical-grade cannabis solutions.
Direct link → Eudra GMP – Public Layout
